Speaking with Daxko, the Thrive doctor argues 'taking peptides' is too vague a phrase and says most products members buy lack any safety data.
Recap by typeshit. Post by Daxko on X.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Oasis reports failures including wrong compounds, low purity and off-label doses in BPC-157, semaglutide and Melanotan II, and says Peptide Gurus passed 9 of 46.
An investor take on Lilly's pipeline. One stat stands out: Lilly said 80% of Foundayo prescriptions went to people new to GLP-1 drugs.
Loading…